Search

Library Entry

Advances in Cancer Immunotherapy™ Webinar Series: Updates from the Field - Clinical Updates from ESMO Immuno-Oncology Congress 2018

This webinar provided an update on developments in the field relating to content presented at the Advances in Cancer Immunotherapy programs and focused on applicable information for a clinical audience. More specifically, program organizers May Cho, MD, and Terence Rhodes, MD, PhD provided...

Web Page

WIN Leadership Institute Schedule

WIN Leadership Institute Schedule 2-Day Program Aug. 19-20, 2019 Monday, Aug. 19, 2019 7:30-8:00 a.m. Registration and Breakfast 8-8:15 a.m. Welcome and Overview Lisa H. Butterfield, PhD – PICI Research Center, Parker Institute for Cancer...

Web Page

Open Comment Period

Web Page

Women in Cancer Immunotherapy Network

WIN Leadership Institute Aug. 19–20, 2019 • Seattle, Wash. Organizers Lisa H. Butterfield, PhD – Parker Institute for Cancer Immunotherapy/University of California San Francisco Mary L. Disis, MD, FACP – University of Washington Olivera J. Finn, PhD – University of Pittsburgh Kristin Hege,...

Library Entry

Vaccinia virus-mediated cancer immunotherapy: cancer vaccines and oncolytics

Published in the Journal for ImmunoTherapy of Cancer (JITC), is a review of the concept of using OV as a unique type of cancer vaccine and the likely superior benefits that would be associated with integrating OVs into combination immunotherapies for improving objective clinical response...

Library Entry

Cutaneous adverse reactions in B-RAF positive metastatic melanoma following sequential treatment with B-RAF/MEK inhibitors and immune checkpoint blockade or vice versa. A single-institutional case-se

Published in the Journal for ImmunoTherapy of Cancer (JITC), is a case report on patients treated with immune-checkpoint blockade followed by targeted therapy, or vice versa, who experienced cutaneous toxicities with unique histological patterns, a feature that has not been well described in...

Library Entry

Advances in Cancer Immunotherapy™ Webinar Series - Updates from the Field: ESMO Congress Clinical Trials Recording

This webinar provided an update on developments in the field relating to content presented at the Advances in Cancer Immunotherapy programs and focused on applicable information for a clinical audience. More specifically, program organizers Theodore F. Logan, MD, and David F. McDermott, MD,...

Library Entry

Primer on Cancer Immunology and Immunotherapy

Primer on Cancer Immunology and Immunotherapy International Conference on Immunotherapy Radiotherapy Combinations September 20, 2018 Presentered by Gustave Roussy and SOCRATE, in collaboration with the Society for Immunotherapy of Cancer Program Summary Over 420 attendees from 4 continents,...

7 attachments

Library Entry

Nephrotoxicity of immune checkpoint inhibitors beyond tubulointerstitial nephritis: single-center experience

Published in the Journal for ImmunoTherapy of Cancer (JITC), is a short report of cases of biopsy proven acute tubulointerstitial nephritis (ATIN) and glomerulonephritis (GN) induced by CPIs and discuss potential mechanisms of these adverse effects. Authors: Omar Mamlouk , Umut Selamet , ...

Library Entry

Complete response of metastatic melanoma in a patient with Crohn’s disease simultaneously receiving anti-α4β7 and anti-PD1 antibodies

Published in the Journal for ImmunoTherapy of Cancer (JITC), is a case report of a man with Crohn’s disease actively requiring immunosuppressive therapy who subsequently received pembrolizumab for metastatic melanoma. Authors: Christopher C. Frohne , Ernesto M. Llano , Ashley Perkovic , ...